Drug Type Small molecule drug |
Synonyms Aprindine, Aprindine hydrochloride (JP17/USAN), Aprindine Hydrochloride Teblets + [11] |
Target |
Mechanism CaM antagonists(Calmodulin antagonists), Nav1.5 blockers(Sodium channel protein type V alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1981), |
Regulation- |
Molecular FormulaC22H31ClN2 |
InChIKeyKIPFVRHNAAZJOD-UHFFFAOYSA-N |
CAS Registry33237-74-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01326 | Aprindine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Tachycardia | JP | 01 Mar 1987 | |
Arrhythmias, Cardiac | CN | 01 Jan 1981 |